Related Experiment Video
Updated: May 8, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
Published on: January 12, 2022
Sarcoid panuveitis associated with etanercept treatment, resolving with adalimumab
D Dragnev1, D Barr, M Kulshrestha
1Hywel Dda Health Board, Aberystwyth Eye Centre, Aberystwyth, UK. damidra5@gmail.com
Abstract:
We presented a case of a 54-year-old woman, who developed sarcoidosis uveitis while on treatment with the tumour necrosis factor α (TNFα) antagonist etanercept for rheumatoid arthritis. Her condition improved, but did not recover completely after the medication was stopped. After starting her on another TNFα antagonist, adalimumab, the uveitis recovered completely. Etanercept and adalimumab are from the same class of medication, but have different effects on other mediators and cells, which may explain these discrepancies.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Pericarditis III: Medical Management
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Nephrotic Syndrome III : Nursing Management
Angle Closure Glaucoma: Treatment
